Last reviewed · How we verify
PF-04308515
At a glance
| Generic name | PF-04308515 |
|---|---|
| Sponsor | Pfizer |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Multiple Dose Escalation Trial Of PF-04308515 In Healthy Volunteers (PHASE1)
- Single Dose Study Of PF-04308515 And Prednisone On Carbohydrate (PHASE1)
- A Phase 1 Single-Dose Escalation Study of PF-04308515 in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PF-04308515 CI brief — competitive landscape report
- PF-04308515 updates RSS · CI watch RSS
- Pfizer portfolio CI